Document is current

Article History

Received: 31 May 2026

Accepted: 31 August 2026

First Online: 7 September 2026

Declarations

Ethics approval and consent to participate: Written informed consent was obtained from all participants after providing detailed explanations regarding the nature of the study. Strict confidentiality was maintained throughout the research, and no personal or identifying information about the patients was disclosed at any stage. It is noteworthy that all procedures performed in this study were solely for therapeutic purposes, with no additional financial burden imposed on the patients. The study protocol was approved by the Ethics Committee of Tabriz University of Medical Sciences under the code IR.TBZMED.REC.1402.390, and the clinical trial was registered in the Iranian Registry of Clinical Trials (IRCT) with the code IRCT20190325043107N58/ . This study was conducted in full accordance with the principles of the Declaration of Helsinki. Given that the authors of the present study are non‑native English speakers and minor linguistic inaccuracies might have occurred during the initial drafting process, the manuscript was subsequently refined using a Large Language Model (LLM) such as ChatGPT to improve clarity and language quality. The authors affirm that this tool—and any similar language‑based applications—was used solely for stylistic enhancement and grammatical correction, and not for data analysis, primary writing, or any other component of the research process.

Consent for publication: There are no patient personal data included in this manuscript.

Competing interests: The authors declare no competing interests.